Level Biotechnology Free Cash Flow Generation Index
Level Biotechnology free cash flow generation index. Level Biotechnology (3118) has a Free Cash Flow Generation Index of 0.62x as of September 2025. Free cash flow of NT$7.37 Million represents 1% of operating cash flow (NT$11.81 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Level Biotechnology (2017–2024)
Free cash flow generation index of Level Biotechnology from 2017 to 2024. Historical FCF Generation Index trend for Level Biotechnology across 8 annual periods. See 3118 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Level Biotechnology Free Cash Flow Generation Index by Year (2017–2024)
Level Biotechnology free cash flow generation index by year from 2017 to 2024. Year-by-year Free Cash Flow Generation Index for Level Biotechnology. For the full cash flow conversion analysis, see Level Biotechnology operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | NT$-159.58 Million | NT$64.10 Million | NT$223.68 Million | ▼ -379.5% |
| 2023 | 0.89x | NT$62.54 Million | NT$70.21 Million | NT$7.67 Million | ▼ -0.6% |
| 2022 | 0.90x | NT$58.33 Million | NT$65.07 Million | NT$6.74 Million | ▼ -4.8% |
| 2021 | 0.94x | NT$146.79 Million | NT$155.95 Million | NT$9.15 Million | ▼ -2.9% |
| 2020 | 0.97x | NT$80.69 Million | NT$83.23 Million | NT$2.54 Million | ▼ -0.8% |
| 2019 | 0.98x | NT$106.60 Million | NT$109.02 Million | NT$2.43 Million | ▲ +7.9% |
| 2018 | 0.91x | NT$24.26 Million | NT$26.77 Million | NT$2.51 Million | ▲ +3.3% |
| 2017 | 0.88x | NT$62.55 Million | NT$71.29 Million | NT$10.83 Million | — |